ArticleJournal of clinical medicine2022

Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study.

Fahad M Althobaiti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.